PATENT CLAIM ANALYSIS

Application Number: 16051612
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-06
Patent Classification: ["514", "262100"]

Abstract:
The present invention provides 1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-ones and 1,5-dihydro-4H-pyrazolo[4,3-c]pyridin-4-ones of formula (I) as PDE1 inhibitors and their use as a medicament, in particular for the treatment of neurodegenerative disorders and psychiatric disorders.

Claim (Index 5):
The compound or tautomer or pharmaceutically acceptable salt thereof of  claim 1 , wherein R 1  is oxetanyl, tetrahydrofuranyl or tetrathydropyranyl.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 96.0
- Lexical Diversity: 1.23529
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['16340429', '15637920', '16033395', '15849798', '15502144']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8291505372348511
- 35 USC 102 Novelty (BERT): 0.5823378573599298
- Combined Prediction Score: 0.8044692692473591
- Mean Citation Score: 404.623846
- Max Citation Score: 509.92545
- Similarity Product: 406.3493352706254

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test